Back to results
US 2014/0371149 A1Published application
Scarring reducing wound treatment
AssigneeSastoMed GmbH
InventorMichael Sander
Life of this patent
Estimating the term…
Abstract
The present invention refers to the use of hemoglobin or myoglobin charged with a non-oxygen ligand for improved scarring of wounds.
Claims20
A method of decreasing undue scarring of healing wounds and/or lowering the relapse rate of wounds, in particular chronic wounds, the method comprising spraying an oxygen carrier or composition on the wound area in form of a fine spray, or applying it to a tissue, band-aid, patch, pad or tampon, which is applied to the wound area.
A composition comprising
- (a) an oxygen carrier;
- and
- (b) at least one further ingredient, selected from electrolyte(s), preservative(s), stabilizer(s), anti-flocculant(s), anticoagulant(s), pH buffering agent(s), solvent(s), antioxidant(s), film-forming agent(s) and crosslinking agent(s).
A composition comprising hemoglobin or myoglobin, charged on its oxygen-binding site with a non-O2 ligand.
(canceled)
Dependencies are inferred from the claim text.